• Username (E-mail)
  • Password
Dow 20,810 0.2%  EStoxx50 3,289 -1.4%  Nikkei 19,284 -0.5%  EUR 1.0609 0.3% 
Nasdaq 5,836 -0.4%  FTSE100 7,217 -0.8%  Yen 112.2350 -0.4%  Oil 56.1 -0.7% 
S&P500 2,364 0.0%  DAX 11,749 -1.7%  GBP 1.2555 0.0%  Gold 1,257 0.6% 

Pfizer share [Symbol: PFE / ISIN: US7170811035]

Realtimequote Pfizer Inc. in USD

Exchange Market
34.01
Last
0
Volume
Time 04:23 PM
02/23/2017 04:23:17 PM UTC-0500
activate push

Stock Price Pfizer Inc. in USD

Activate push
34.06 USD 0.47 USD 1.40 %
Trade Time 4:15 PM Trade Date 2/23/2017
Daily High 0.00 Open 0.00
Daily Low 0.00 Prev. Close 34.06
52-week High 37.39 Volume (Qty.) 0
52-week Low 28.74 Market Cap (USD) 205.37 B
52-week Perf.
Exchange

Analyst Opinions for Pfizer Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
02/17/17
Pfizer Jefferies & Company Inc.
02/17/17
Pfizer Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02/02/17
Pfizer Morningstar
02/01/17
Pfizer Atlantic Equities
01/24/17
Pfizer Bernstein Research

Moody's Rating for Pfizer Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A1
Rating Update AFF
Date of Rating 5/16/2016
Rating Office USA

Profile Pfizer Inc.

Company Profile
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.
pagehit

Add or Edit Instrument

Pfizer Chart - 1 Year - NYSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NYSE
  • Chart Options

Estimates for Pfizer

2016 2017e 2018e
Dividend 1.20 1.28 1.47
Dividend Yield in % 3.69 3.79 4.37
P/E Ratio 13.54 13.13 12.10
EPS 2.40 2.57 2.79

ANALYST DATA FOR Pfizer

Sell
Hold
Buy
33
34
35
36
37
38
39
40


Pfizer Key Figures

Market Cap (USD) 205.37 B
Free Float in % 99.93
Number of Shares (Mio.) 6,068.36
Cash Flow per Share 2.07
Book Value per Share 9.84
60-Days Volatility 19.39
P/B Ratio 3.30

Base Data Pfizer

Symbol PFE
ISIN US7170811035
Indices Dow Jones, S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

About the Company Pfizer

Country USA

Pfizer Historical Prices

02/21/2017
02/21/2017 06:00:00 PM UTC-0500
33.59 8,905,666
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
33.62 7,764,656
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
33.62 13,553,774
02/15/2017
02/15/2017 06:00:00 PM UTC-0500
33.62 7,885,454
02/14/2017
02/14/2017 06:00:00 PM UTC-0500
33.51 11,175,304

Pfizer Peer Group

Abbott Laboratories 45.40
0.9%
Alexion Pharmaceuticals 130.44
-0.3%
AstraZeneca 45.80
-0.4%
Bayer 104.25
-0.7%
Celgene 119.46
0.2%
EVOTEC 7.12
-3.1%
Gilead Sciences 69.37
0.8%
GlaxoSmithKline 16.19
-0.8%
Johnson & Johnson 121.70
1.8%
Merck 65.85
0.9%
Merck 102.30
-0.5%
MorphoSys 52.17
-1.5%
Mylan 42.33
0.8%
Novartis 77.10
-0.7%
Pfizer 34.06
1.4%
Roche 246.10
-1.1%
STADA Arzneimittel 57.72
0.0%
Sanofi 79.68
-0.5%
Teva Pharmaceutical Industries 35.82
-0.4%
Vertex Pharmaceuticals 85.73
-0.1%

Similar shares with higher 1-year perf.